Correlation Between BZDYF and Zenas BioPharma,
Can any of the company-specific risk be diversified away by investing in both BZDYF and Zenas BioPharma, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BZDYF and Zenas BioPharma, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between BZDYF and Zenas BioPharma, Common, you can compare the effects of market volatilities on BZDYF and Zenas BioPharma, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BZDYF with a short position of Zenas BioPharma,. Check out your portfolio center. Please also check ongoing floating volatility patterns of BZDYF and Zenas BioPharma,.
Diversification Opportunities for BZDYF and Zenas BioPharma,
-0.74 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between BZDYF and Zenas is -0.74. Overlapping area represents the amount of risk that can be diversified away by holding BZDYF and Zenas BioPharma, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Zenas BioPharma, Common and BZDYF is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BZDYF are associated (or correlated) with Zenas BioPharma,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Zenas BioPharma, Common has no effect on the direction of BZDYF i.e., BZDYF and Zenas BioPharma, go up and down completely randomly.
Pair Corralation between BZDYF and Zenas BioPharma,
Assuming the 90 days horizon BZDYF is expected to generate 0.08 times more return on investment than Zenas BioPharma,. However, BZDYF is 11.83 times less risky than Zenas BioPharma,. It trades about 0.24 of its potential returns per unit of risk. Zenas BioPharma, Common is currently generating about -0.12 per unit of risk. If you would invest 3,086 in BZDYF on September 22, 2024 and sell it today you would earn a total of 151.00 from holding BZDYF or generate 4.89% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 58.57% |
Values | Daily Returns |
BZDYF vs. Zenas BioPharma, Common
Performance |
Timeline |
BZDYF |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Zenas BioPharma, Common |
BZDYF and Zenas BioPharma, Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with BZDYF and Zenas BioPharma,
The main advantage of trading using opposite BZDYF and Zenas BioPharma, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BZDYF position performs unexpectedly, Zenas BioPharma, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Zenas BioPharma, will offset losses from the drop in Zenas BioPharma,'s long position.BZDYF vs. FT Vest Equity | BZDYF vs. Zillow Group Class | BZDYF vs. Northern Lights | BZDYF vs. VanEck Vectors Moodys |
Zenas BioPharma, vs. Dogwood Therapeutics, | Zenas BioPharma, vs. Eupraxia Pharmaceuticals Common | Zenas BioPharma, vs. CERo Therapeutics Holdings | Zenas BioPharma, vs. Opus Genetics, |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Other Complementary Tools
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
CEOs Directory Screen CEOs from public companies around the world |